FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2461422596> ?p ?o ?g. }

• W2461422596 endingPage "598" @default.
• W2461422596 startingPage "590" @default.
• W2461422596 abstract "Aspirin (ASA)-exacerbated respiratory disease (AERD) is characterized by upper airway congestion due to eosinophilic inflammation of the nasal and sinus membranes and nasal polyposis, associated with increased leukotriene production that is further accentuated by ASA or other nonsteroidal anti-inflammatory drug (NSAID) ingestion. It occurs in 5% to 10% of subjects with chronic rhinosinusitis (CRS) and in 15% to 40% of those with nasal polyposis. Although AERD with CRS is usually associated with asthma, this is not always the case. The eosinophilic airway inflammation and symptoms precede clinical reactions to ASA or other NSAIDs, but ultimately affected subjects experience worsening of symptoms with ingestion of ASA/NSAIDs. The endotypic mechanism for this worsening is related to a chronic increase in leukotriene and a decrease in prostaglandin production, particularly prostaglandin E2, that is further aggravated by the inhibition of cycloxgenase I. IgE does not likely play a role in the pathogenesis of the disease although nasal and sinus staphylococcal infection increases local IgE level and may increase total IgE and specific IgE levels. Genetic studies suggest that multiple genes may be involved, but the genetic abnormalities may differ in affected subjects from different ethnicities and candidate genes have not been confirmed in multiple studies. Genome-wide association studies have not been revealing. The phenotype is recognized by the mucosal inflammation and worsening of symptoms acutely with ASA/NSAID. There is clinical improvement with ASA desensitization followed by regular ingestion of ASA or other NSAIDs. Further understanding of this unique phenotype and endotype of CRS will likely improve the understanding of other eosinophilic airway diseases. Aspirin (ASA)-exacerbated respiratory disease (AERD) is characterized by upper airway congestion due to eosinophilic inflammation of the nasal and sinus membranes and nasal polyposis, associated with increased leukotriene production that is further accentuated by ASA or other nonsteroidal anti-inflammatory drug (NSAID) ingestion. It occurs in 5% to 10% of subjects with chronic rhinosinusitis (CRS) and in 15% to 40% of those with nasal polyposis. Although AERD with CRS is usually associated with asthma, this is not always the case. The eosinophilic airway inflammation and symptoms precede clinical reactions to ASA or other NSAIDs, but ultimately affected subjects experience worsening of symptoms with ingestion of ASA/NSAIDs. The endotypic mechanism for this worsening is related to a chronic increase in leukotriene and a decrease in prostaglandin production, particularly prostaglandin E2, that is further aggravated by the inhibition of cycloxgenase I. IgE does not likely play a role in the pathogenesis of the disease although nasal and sinus staphylococcal infection increases local IgE level and may increase total IgE and specific IgE levels. Genetic studies suggest that multiple genes may be involved, but the genetic abnormalities may differ in affected subjects from different ethnicities and candidate genes have not been confirmed in multiple studies. Genome-wide association studies have not been revealing. The phenotype is recognized by the mucosal inflammation and worsening of symptoms acutely with ASA/NSAID. There is clinical improvement with ASA desensitization followed by regular ingestion of ASA or other NSAIDs. Further understanding of this unique phenotype and endotype of CRS will likely improve the understanding of other eosinophilic airway diseases." @default.
• W2461422596 created "2016-07-22" @default.
• W2461422596 creator A5004381470 @default.
• W2461422596 creator A5014470416 @default.
• W2461422596 date "2016-07-01" @default.
• W2461422596 modified "2023-09-24" @default.
• W2461422596 title "Aspirin or Nonsteroidal Anti-inflammatory Drug–Exacerbated Chronic Rhinosinusitis" @default.
• W2461422596 cites W1591869705 @default.
• W2461422596 cites W1968876836 @default.
• W2461422596 cites W1978596588 @default.
• W2461422596 cites W1980656155 @default.
• W2461422596 cites W1981267238 @default.
• W2461422596 cites W1999762430 @default.
• W2461422596 cites W2002473719 @default.
• W2461422596 cites W2002594807 @default.
• W2461422596 cites W2013564896 @default.
• W2461422596 cites W2022356304 @default.
• W2461422596 cites W2031990154 @default.
• W2461422596 cites W2033514267 @default.
• W2461422596 cites W2038199642 @default.
• W2461422596 cites W2042059115 @default.
• W2461422596 cites W2046583756 @default.
• W2461422596 cites W2049001714 @default.
• W2461422596 cites W2065302886 @default.
• W2461422596 cites W2067046525 @default.
• W2461422596 cites W2071999184 @default.
• W2461422596 cites W2077464872 @default.
• W2461422596 cites W2086309760 @default.
• W2461422596 cites W2087018319 @default.
• W2461422596 cites W2087621979 @default.
• W2461422596 cites W2090761238 @default.
• W2461422596 cites W2092011336 @default.
• W2461422596 cites W2092273117 @default.
• W2461422596 cites W2093361150 @default.
• W2461422596 cites W2094165155 @default.
• W2461422596 cites W2097278548 @default.
• W2461422596 cites W2105880697 @default.
• W2461422596 cites W2119410661 @default.
• W2461422596 cites W2119753383 @default.
• W2461422596 cites W2125758213 @default.
• W2461422596 cites W2129271442 @default.
• W2461422596 cites W2130907702 @default.
• W2461422596 cites W2135254592 @default.
• W2461422596 cites W2136073528 @default.
• W2461422596 cites W2140124854 @default.
• W2461422596 cites W2143107663 @default.
• W2461422596 cites W2156816257 @default.
• W2461422596 cites W2157681529 @default.
• W2461422596 cites W2160363614 @default.
• W2461422596 cites W2160471996 @default.
• W2461422596 cites W2185828908 @default.
• W2461422596 cites W2202379982 @default.
• W2461422596 cites W2266684950 @default.
• W2461422596 cites W2301812171 @default.
• W2461422596 cites W2315004065 @default.
• W2461422596 cites W2327411090 @default.
• W2461422596 cites W930040673 @default.
• W2461422596 doi "https://doi.org/10.1016/j.jaip.2016.04.011" @default.
• W2461422596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27393773" @default.
• W2461422596 hasPublicationYear "2016" @default.
• W2461422596 type Work @default.
• W2461422596 sameAs 2461422596 @default.
• W2461422596 citedByCount "17" @default.
• W2461422596 countsByYear W24614225962016 @default.
• W2461422596 countsByYear W24614225962017 @default.
• W2461422596 countsByYear W24614225962018 @default.
• W2461422596 countsByYear W24614225962020 @default.
• W2461422596 countsByYear W24614225962021 @default.
• W2461422596 countsByYear W24614225962022 @default.
• W2461422596 countsByYear W24614225962023 @default.
• W2461422596 crossrefType "journal-article" @default.
• W2461422596 hasAuthorship W2461422596A5004381470 @default.
• W2461422596 hasAuthorship W2461422596A5014470416 @default.
• W2461422596 hasConcept C126322002 @default.
• W2461422596 hasConcept C203014093 @default.
• W2461422596 hasConcept C2776042228 @default.
• W2461422596 hasConcept C2776452501 @default.
• W2461422596 hasConcept C2776914184 @default.
• W2461422596 hasConcept C2777628954 @default.
• W2461422596 hasConcept C2777768476 @default.
• W2461422596 hasConcept C2781390199 @default.
• W2461422596 hasConcept C71924100 @default.
• W2461422596 hasConceptScore W2461422596C126322002 @default.
• W2461422596 hasConceptScore W2461422596C203014093 @default.
• W2461422596 hasConceptScore W2461422596C2776042228 @default.
• W2461422596 hasConceptScore W2461422596C2776452501 @default.
• W2461422596 hasConceptScore W2461422596C2776914184 @default.
• W2461422596 hasConceptScore W2461422596C2777628954 @default.
• W2461422596 hasConceptScore W2461422596C2777768476 @default.
• W2461422596 hasConceptScore W2461422596C2781390199 @default.
• W2461422596 hasConceptScore W2461422596C71924100 @default.
• W2461422596 hasIssue "4" @default.
• W2461422596 hasLocation W24614225961 @default.
• W2461422596 hasLocation W24614225962 @default.
• W2461422596 hasOpenAccess W2461422596 @default.
• W2461422596 hasPrimaryLocation W24614225961 @default.
• W2461422596 hasRelatedWork W111705108 @default.
• W2461422596 hasRelatedWork W1943316663 @default.

• next